MTOR and lung carcinoma: Based on transcriptomic analysis, we expect to further investigate the molecular mechanisms of metochalcone that involve the NGFR-AMPK-mTOR pathway in lung cancer and METTL7A-mediated RNA m6a methylation and ferroptosis in breast cancer.